| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Rafael López | |
| Yolanda Escobar | |||
| Cesar Margarit | |||
| Juan Jesús Cruz | |||
| Antonio Anton | |||
| Ana Mañas | |||
| Francisco Zaragozá | |||
| Ana Casas | |||
| Rafael Galvez | |||
| Joaquim Juliá | |||
| P2860 | cites work | Breakthrough pain: definition, prevalence and characteristics | Q33435886 |
| Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. | Q34251507 | ||
| Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care | Q34539972 | ||
| Impact and management of breakthrough pain in cancer | Q34975545 | ||
| Quality of life and symptom burden among long-term lung cancer survivors | Q35621522 | ||
| Breakthrough pain: characteristics and impact in patients with cancer pain. | Q51089873 | ||
| Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. | Q53288431 | ||
| Oncologists’ perceptions of cancer pain management in Spain: The real and the ideal | Q61917225 | ||
| Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group | Q72222047 | ||
| A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain | Q79301299 | ||
| [Cancer-related breakthrough pain] | Q84184108 | ||
| Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice | Q84431168 | ||
| Breakthrough cancer pain: mending the break in the continuum of care | Q84868270 | ||
| A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer | Q35846556 | ||
| Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms | Q36057778 | ||
| Prevalence of pain in patients with cancer: a systematic review of the past 40 years | Q36758835 | ||
| The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. | Q37245357 | ||
| The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing | Q37826856 | ||
| Integrated strategies for the successful management of breakthrough cancer pain | Q37843304 | ||
| The management of breakthrough cancer pain. | Q37917548 | ||
| Pharmacotherapy for breakthrough cancer pain | Q37974707 | ||
| Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patients | Q37994343 | ||
| Linking palliative care and oncology practice: performance status as a common thread | Q39203695 | ||
| Professional survey on knowledge and clinical patterns of pain management in Spanish medical oncology | Q39275298 | ||
| Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes | Q39307077 | ||
| Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses. | Q42504553 | ||
| Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain | Q44105804 | ||
| The prevalence of episodic pain in cancer: a survey of hospice patients on admission | Q44221667 | ||
| Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. | Q46848752 | ||
| Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies | Q48294458 | ||
| Medical oncologists' attitudes and practice in cancer pain management: a national survey | Q48565403 | ||
| The role of pain in head and neck cancer recurrence and survivorship | Q49078482 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | cancer pain | Q3712728 |
| P304 | page(s) | 559-566 | |
| P577 | publication date | 2012-11-19 | |
| P1433 | published in | Journal of Pain Research | Q6295704 |
| P1476 | title | Breakthrough cancer pain - still a challenge | |
| P478 | volume | 5 |
| Q34756223 | Breakthrough pain in patients with controlled or uncontrolled basal pain: an observational study |
| Q36807866 | Canadian recommendations for the management of breakthrough cancer pain |
| Q86955641 | Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON) |
| Q92609980 | Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets |
| Q37194580 | Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain |
| Q47196254 | Nitrous oxide/oxygen mixture for analgesia in adult cancer patients with breakthrough pain: A randomized, double-blind controlled trial |
| Q55165284 | Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm. |
| Q92354755 | Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain |
| Q47285618 | SEOM clinical guideline for treatment of cancer pain (2017). |
| Q39216977 | Safety profile of intravenous patient-controlled analgesia for breakthrough pain in cancer patients: a case series study. |
| Q37053311 | Single-dose fentanyl sublingual spray for breakthrough cancer pain |
| Q26750732 | The Impact of Massage Therapy on Function in Pain Populations-A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Part II, Cancer Pain Populations |
| Q57286683 | The efficacy of oral piroxicam fast-dissolving tablets versus sublingual fentanyl in incident breakthrough pain due to bone metastases: a double-blinded randomized study |
| Q28069133 | What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion |
Search more.